Skip to main content
BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
0.203
+0.001 (0.50%)
At close: Dec 20, 2024, 4:00 PM
0.208
+0.005 (2.66%)
After-hours: Dec 20, 2024, 6:31 PM EST

BioLineRx Revenue

BioLineRx had revenue of $4.94M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $21.99M. In the year 2023, BioLineRx had annual revenue of $4.80M.

Revenue (ttm)
$21.99M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$278,367
Employees
79
Market Cap
19.08M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.80M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Concord Medical Services Holdings 64.91M
Retractable Technologies 38.27M
CervoMed 10.07M
Bolt Biotherapeutics 9.78M
Affimed 6.29M
Alterity Therapeutics 2.68M
Palatin Technologies 2.38M
Revenue Rankings

BLRX News

More News